Brian Birchler, EVP, Corporate and Development Operations at IONIS PHARMACEUTICALS INC (IONS), sold 47,800 shares at $72.03 ($3.4M) on 2025-10-14, disclosed to the SEC on 2025-10-16.
Scheduled sale ($3.4M) by EVP, Corporate and Development Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.03 | 11,475 | $827K | 24.0% |
| 2 | $72.03 | 11,475 | $827K | 24.0% |
| 3 | $72.23 | 12,425 | $897K | 26.0% |
| 4 | $72.23 | 12,425 | $897K | 26.0% |
| Total | $72.13 avg | 47,800 | $3.4M | 100% |
| Filing → |
| IONS | SELL | 2026-01-20 | $637K | — | Filing → |
| IONS | SELL | 2025-11-07 | $609K | — | Filing → |
| IONS | SELL | 2025-04-17 | $19K | — | Filing → |